Nurix Therapeutics, Inc. Common stock (NRIX) Stock Price, Quote & AI Analysis
Live NRIX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Nurix Therapeutics, Inc. Common stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Nurix Therapeutics, Inc. Common stock (NRIX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Nurix Therapeutics, Inc. Common stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Nurix Therapeutics, Inc. Common stock Overview
Company information
Company Overview
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Nurix Therapeutics, Inc. Common stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...